Conavi Medical Corp. is a medical technology firm that specializes in developing, manufacturing, and commercializing advanced imaging solutions. These innovations are specifically designed to provide guidance during minimally invasive cardiovascular procedures. A notable product is the Novasight Hybrid System, which uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. This enables clinicians to obtain simultaneous and precisely co-registered images of the coronary arteries. Conavi Medical Corp. is headquartered in Toronto, Canada.
Show more...
FAQ
Conavi Medical 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 Boerse Muenchen 交易所,Conavi Medical 的股票以代號 YU1.MU 進行交易。
Conavi Medical 下一次財報日期是什麼時候?▼
Conavi Medical 將於 December 17, 2026 公布下一次財報。
Conavi Medical 上一季度的財報如何?▼
YU1.MU 上一季度的財報為每股 -0.04 EUR,預估為 不適用 EUR,帶來 不適用 的驚喜。下一季度的預估財報為每股 不適用 EUR。
Conavi Medical 去年的營收是多少?▼
Conavi Medical 去年的營收為 5.85MEUR。
Conavi Medical 去年的淨利是多少?▼
YU1.MU 去年的淨收益為 -13.91MEUR。
Conavi Medical 有多少名員工?▼
截至 September 11, 2026,公司共有 4 名員工。
Conavi Medical 位於哪個產業?▼
Conavi Medical從事於Health & Wellness產業。
Conavi Medical 何時完成拆股?▼
Conavi Medical 最近沒有進行任何拆股。
Conavi Medical 的總部在哪裡?▼
Conavi Medical 的總部位於 加拿大 的 Toronto。